Minimally Invasive Surgery

Cutting Edge Laser Technologies manufactures therapeutic and surgical laser systems for medical and veterinary applications. The company specializes in patented, FDA-cleared Class IV laser technologies, including the MLS® Laser Therapy platform for medical rehabilitation and pain management, and CO2 surgical laser systems for veterinary minimally invasive procedures. With 25 years of operating history, Cutting Edge serves medical practices, rehabilitation centers, and veterinary clinics across the United States and Canada. Their MLS® technology is based on decades of clinical research and validation by world-renowned institutions. The company reports treating over 15 million patients and animals annually worldwide. Products are designed to improve clinical outcomes, increase patient satisfaction, and create new revenue opportunities for healthcare providers. The MLS® Laser Therapy line addresses musculoskeletal conditions, pain management, and tissue healing, while veterinary CO2 laser surgery systems offer precision in minimally invasive surgical applications for veterinary medicine.

Xtant Medical is a Montana-based tissue bank and vertically integrated orthobiologics company with 25 years of clinical experience. The company develops and manufactures a comprehensive portfolio of allogeneic bone grafts, biologics, and allogeneic proteins for orthopedic and spinal surgery, complemented by spinal fixation systems (cervical, thoracolumbar, and interbody implants). Core product lines include OsteoFactor Pro (allogeneic growth factors), OsteoVive Plus (viable bone matrix allograft), OsteoSelect (engineered bone graft), and Trivium (multi-element biologic system). Xtant operates with full vertical integration from donor recovery through processing, quality assurance, and distribution, ensuring traceability and clinical consistency. The company serves orthopedic surgeons, spinal surgeons, and complex/deformity procedure specialists. Xtant's mission emphasizes honoring tissue donation and patient outcomes. The company maintains state-of-the-art processing capabilities and patented, clinically validated technology. While specific FDA clearances are not explicitly detailed in the fetched content, the 25-year track record and market presence indicate regulatory compliance. Xtant positions itself as a single-source provider for both biologics and spinal fixation, differentiating through integrated R&D and manufacturing.

Norwood Medical is a contract manufacturer and precision engineering partner specializing in medtech component and device manufacturing. Operating from a 700,000 square-foot manufacturing campus in Dayton, Ohio, the company serves leading surgical device manufacturers across cardiovascular, minimally invasive surgery (MIS), orthopedic, and robotic-assisted surgery (RAS) markets. Founded nearly a century ago, Norwood offers end-to-end capabilities spanning design for manufacturability (DFM), engineering, prototyping, tooling development, precision machining, metal injection molding (MIM), electro-chemical machining (ECM), automation, secondary processing, assembly, testing, and packaging. The company operates over 800 CNC machines (milling, turning, 5-axis, Swiss machining), automated robotic systems with vision and laser technology, and specialized electrochemical machining equipment. Norwood manufactures components at tight tolerances for complex surgical instruments and implantable devices, with in-house capabilities for metal injection molding feedstock mixing and insert molding. The firm maintains strong quality and on-time delivery metrics and serves as sole supplier to approximately 32% of its customer base. Quality certifications and regulatory compliance capabilities support OEM partners across FDA-regulated device categories.

Viant Medical is a vertically integrated contract manufacturing partner specializing in medical device design, development, and full-scale production. The company operates 25 global locations with 2.3 million square feet of factory space, including 299,000+ square feet of ISO-certified clean room capacity. Viant serves OEMs across multiple clinical markets: orthopedics (instruments, implants, delivery systems, UHMWPE components), surgical technologies (minimally invasive surgery, robotics, endoscopy, ophthalmology, wound care, biopsy, aesthetic surgery), cardiac and interventional devices (overmolding, nitinol tubing, hypotube precision components), drug delivery (auto-injectors, IV sets, connectors, respiratory devices), bioprocessing (containment, transfer, filtration systems), bioelectronics (pain management, sleep apnea, wearables), diagnostics and laboratory products (injection tubes, chromatography tubing), and respiratory/monitoring/patient care (masks, trach tubes, airway tubes, console components). Core manufacturing capabilities include precision metals and metal tubing, medical-grade plastics and silicone molding, extrusions, tooling, automation, device assembly, and finished device services. The company provides end-to-end solutions from prototyping through sterilization and packaging management. Viant emphasizes vertical integration to ensure quality control, reduce supply chain risk, and accelerate time-to-market. The ViaLaunch™ program offers program management support. The company focuses exclusively on medical device manufacturing and maintains operational expertise in complex assembly, overmolding, and materials science.

Atlas Spine Inc. designs, manufactures, and markets minimally invasive implants and instrument systems for the treatment of spinal pathologies. The company specializes in innovative spine implant technology, with a focus on height and lordosis restoration. Atlas has established itself as a design resource for spine surgeons and major medical device manufacturers. The company develops disruptive technologies for spine care, working closely with leading spine surgeons to create cost-effective, high-quality, and clinically efficacious systems. Their product portfolio includes expandable implant technology such as HiJak AC (Anterior Cervical), designed for superior height and lordosis restoration, particularly at the cervicothoracic junction. The HiJak system enables surgeons to improve patient chin-brow angle outcomes compared to traditional non-expandable implant technology. Atlas serves hospitals and surgical centers requiring advanced minimally invasive spine solutions.

Nissha Medical Technologies is a global design and contract manufacturing partner specializing in single-use medical technologies and clinical consumables. Operating under parent company Nissha (established 1929, publicly traded), the organization manufactures and distributes patient monitoring equipment, medical surgical consumables, and complex minimally invasive surgical devices. Core capabilities include clinical wearables with electronics and sensor integration, minimally invasive surgical device design and fabrication, clinical accessories, cable assemblies, and specialty packaging. The company serves hospitals and clinical centers across North America, Europe, and Japan, with direct sales and customer service teams; additionally distributes through an authorized distributor network reaching over 60 countries. Manufacturing and innovation centers span multiple locations: Buffalo, NY (global corporate headquarters), Torbay, UK (European headquarters), Cergy, France, Innsbruck, Austria (regulatory center), Colorado Springs, CO, Sandpoint, ID (innovation center), Nashville, TN (engineering center of excellence), Norwalk, OH, New Richmond, WI, and Dominican Republic. The company offers private-label product options and leverages decades of experience in precision manufacturing. Founded as Graphic Controls in 1909, the organization maintains expertise in printed and converted medical products for industrial and clinical monitoring applications.

CMF Medicon Surgical, Inc. (trading as MEDICON eG) is a German cooperative medical technology manufacturer based in Tuttlingen, founded in 1941. Operating across 11 production facilities with approximately 400 employees, the company specializes in precision-engineered surgical instruments and implant systems for general surgery, plastic surgery, ENT, craniomaxillofacial (CMF), and neurosurgical/spinal applications. The company manufactures over 35,000 medical products and is recognized for innovations including the Neuro Fixation System, mediExpand cervical (distraction system), SegmentDistractor (jaw segment advancement), Epiplating (titanium plate systems), and Hybrid Plate System for mandibular reconstruction. Medicon offers comprehensive support services: instrument repair and maintenance (MRS—Medicon Reparatur Service), surgeon-led training courses (Medicon Courses), sterilization container systems (MediconTainer), microsurgical instruments, and a digital product portal (Medicon HUB and Medicon Extranet). With subsidiaries in Jacksonville, USA, and Mumbai, India, the company distributes to over 120 countries and emphasizes long-term partnerships with surgeons, clinics, and distributors.

NeuWave Medical, Inc., a wholly owned subsidiary of Quantum Surgical, Inc., specializes in developing and commercializing energy-based minimally invasive microwave ablation systems for soft tissue treatment. The company's flagship NeuWave™ Microwave Ablation System is indicated for percutaneous, open surgical, and laparoscopic-assisted ablation of non-resectable liver tumors and soft tissue lesions. The system features ABLATE-IQ™ technology for pre- and post-ablation scan fusion and margin confirmation, Tissu-Loc™ technology using CO2 cooling to minimize probe migration, and a comprehensive probe portfolio including the PRS35 probe with 35cm length for enhanced anatomical reach. The system supports multi-probe synchrony (1–3 probes) to create larger, more spherical ablation zones tailored to individual patient anatomy. Having served over 100,000 patients worldwide, NeuWave continues to pioneer microwave ablation standards and deliver clinical support through live case assistance, virtual clinical concierge services, and comprehensive procedural guidance resources.

S2S Surgical designs and manufactures minimally invasive surgical solutions for upper extremity procedures, including hand, wrist, and elbow surgery. The company develops innovative instrumentation and techniques that preserve soft tissues while providing direct access to surgical sites, enabling simpler, faster procedures with reduced patient pain and recovery time. Founded and led by upper extremity surgeons, S2S Surgical combines clinical expertise with precision engineering to address common upper extremity pathologies. Key products include the Trigger Finger Release System, ECuTR ClearCision System, and FaST CTR System with Barco Blade, each designed to minimize scar tissue formation and optimize surgical visualization. The company's anatomically accurate virtual models of the upper extremity support product development and surgical planning.

Marrow Access Technologies is a medtech company specializing in minimally invasive orthopedic surgical solutions for cartilage repair and regeneration. The company's flagship product, the SmartShot marrow access device, was launched in 2021 and represents an advancement over traditional microfracture techniques. The SmartShot device creates precise microchannels that provide superior access to stem cell-rich bone marrow with significantly less disruption to native bone structure. Clinical data demonstrates 2X greater marrow exposure and 66% less bone disruption compared to conventional mallet-based microfracture. The device is suitable for various weight-bearing joints including the knee, hip, and ankle, and can be used for standalone marrow stimulation therapy or in combination with biological agents. A specialized SmartShot Ankle device addresses the unique anatomical challenges of treating cartilage lesions in the ankle joint. The company partners with Spartan Medical to deliver cartilage repair therapy to U.S. military veterans and active Department of Defense service members.

pfm medical gmbh is a family-owned medical technology manufacturer based in Cologne, Germany, established in 1971. The company develops, manufactures, and distributes approximately 1,800 specialized medical products across four main therapeutic areas: surgery, cardiovascular technologies, histotechnology, and infusion solutions. Key product lines include DURAMESH™ suturable meshes for breast reconstruction and pelvic floor surgery, Nit Occlud® spiral systems for cardiac defect closure, and advanced histology laboratory equipment including the award-winning pfm Forceps EWF 600 wireless heated forceps and the Samui® cooling plate for tissue sample preparation. The company also offers intraoperative imaging solutions such as the ClearCoast™ MRI system for real-time tissue analysis during breast conservation procedures. With over 50 years of operational experience, pfm medical operates 12 locations across 8-10 countries and exports to more than 100 markets worldwide. The company provides comprehensive customer support including compliance training, user education, and technical services to healthcare facilities, medical practices, laboratories, nursing services, and home care providers.

UC-Care develops innovative, fully automated end-to-end solutions for prostate cancer diagnosis and treatment, specifically MRI-ultrasound fusion-guided biopsy and focal therapy procedures. The company's core offering integrates real-time patient motion compensation and automated image processing to enable precise lesion targeting and specimen management. UC-Care's solutions—including the Navigo 4D fusion navigation system, SmartBx biopsy management platform, and FusionStudio DICOM contouring software—are designed to adapt seamlessly to existing clinical workflows in physician practices, ASCs, and hospital settings. The technology delivers improved cancer detection rates (25% increase documented), maintains diagnostic precision despite patient movement, and provides cost-effective fusion-guided biopsy capabilities previously limited to specialized centers. Products are developed with deep understanding of physician and technician realities to minimize workflow disruption while maximizing procedural accuracy and reimbursement alignment.

SpineNet is a manufacturer and solutions provider specializing in spinal fusion devices and orthopedic implants. The company offers a comprehensive portfolio of state-of-the-art anterior cervical fusion systems, including the SpineNet SSP (Single-Screw Plate) System and SpineNet ACC (Anterior Cervical Cage) System, both FDA 510(k) cleared. SpineNet's implants are designed to address cervical spine pathology through minimally invasive techniques, featuring advanced materials such as PEEK and leveraging tri-cortical iliac crest bone graft technology. The company partners with surgeon champions and industry leaders to deliver high-quality medical implants with elite service and clinical support. SpineNet serves the orthopedic surgical and neurosurgical community through direct relationships with surgeons and distributor networks.

LightningCath is an ISO 13485-certified medical device manufacturer specializing in the design, prototyping, and manufacturing of high-quality catheter systems and components for minimally invasive procedures. Based in Brooklyn Park, Minnesota, the company operates an ISO 7 cleanroom facility and emphasizes rapid turnaround times to serve smaller medical device companies and healthcare professionals. LightningCath offers comprehensive catheter manufacturing services including design and prototyping, extrusion (single and multi-lumen thermoplastic and fluoropolymer tubing), injection molding, electrode assembly, and value-added services such as shape setting, tipping, micro-molding, crimping, and balloon bonding. The company supports applications across intravenous therapy, neurovascular interventions, and structural heart procedures, with capabilities ranging from low-to-high volume production and quick-turn development cycles.

TaeWoong Medical Co., Ltd. is a South Korean medical device manufacturer founded in 1991, specializing in minimally invasive medical devices with a global footprint in over 70 countries. The company is recognized for its self-expandable metallic stents under the Niti-S™ brand, securing CE certification (2000) and regulatory approvals in Japan, USA, and China. TaeWoong Medical's product portfolio spans gastroenterology, urology, and interventional cardiology, including biliary stents, pancreatic stents, and endoscopic RFA (radiofrequency ablation) accessories. Recent innovations include PULSTA™, a CE MDR Class III certified pulmonary valve for congenital interventional cardiology. The company emphasizes quality, patient outcomes, and ongoing R&D, with active participation in major international medical conferences (DDW, UEGW, APDW, ESGE, JCIC).

Nanjing Devin Medical Technology Co., Ltd. is a National High-Tech Enterprise specializing in intelligent precision interventional therapy and minimally invasive ablation systems. Operating as a vertically integrated medical device manufacturer with R&D at its core, the company develops and manufactures MRI-compatible ablation systems, microwave ablation equipment, radiofrequency (RF) ablation closure systems, and interventional puncture consumables. With over 100 patents, a 12,000+ m² manufacturing facility, and collaborations with leading Chinese universities and research institutions, Devin Medical serves over 500 customers worldwide. The company provides ODM and OEM manufacturing capabilities for ablation products and integrated solutions. Applications include minimally invasive ablation procedures for solid tumors, benign nodules, respiratory interventional ablation, vascular interventional ablation, and surgical hemorrhoid treatment. The company is a member of the Jiangsu Medical Device Association and holds multiple innovation recognitions.

GI Windows Surgical is a medical technology company specializing in innovative anastomotic technology using self-forming magnets to enable less invasive gastrointestinal surgical procedures. The company's core products—Flexagon™ Self-forming Magnets and Otoloc™ Access System—both FDA 510(k) cleared, facilitate the creation of surgical connections in the GI tract without sutures or staples. This represents the first significant breakthrough in anastomotic procedures in over 40 years. The technology demonstrates superior healing outcomes compared to traditional staplers in preclinical studies and clinical publications, with applications across bariatric, colorectal, and general surgical oncology. The company, founded as a spin-out from Beacon Endoscopic and headquartered in Westwood, Massachusetts, is backed by prominent investors including Johnson & Johnson and has secured significant funding for clinical development and commercialization.

Ontogen Medtech is a full-service medical device development and contract manufacturing partner based in Lisle, Illinois. Founded in 2021, the company specializes in end-to-end product realization for Class I, II, and III medical devices and in-vitro diagnostics across multiple therapeutic areas including orthopedics, cardiovascular, neurosurgery, women's health, pediatrics, and airway management. Services encompass strategic product design, engineering, prototyping, verification and validation testing, regulatory management (FDA compliance, 510(k) support), design history file documentation, and contract manufacturing from pilot builds to large-scale production. Ontogen operates a state-of-the-art facility with Class 7 cleanroom capabilities and sterilization coordination expertise. The team brings over 45 years of combined experience in sensor-driven smart devices, minimally invasive catheters, drug preparation and infusion systems, and class III implants. The company serves entrepreneurs, startups, and established medical device organizations, with a track record supporting clients through SBIR grants, pitch competitions, patent filings, and FDA clearances.

LightScalpel is an American-based surgical CO2 laser designer and manufacturer established in 1991 and located in Bothell, Washington. The company engineers and produces flexible fiber waveguide CO2 laser systems for soft-tissue surgical procedures. LightScalpel's laser engineers bring over 300 years of combined technical expertise in industrial and medical CO2 laser markets. The company manufactures three primary laser system models: the LS-1005 (entry-level dental laser), the LS-2010 (mid-range surgical/dental system), and the LS-4020 (high-performance surgical platform). All systems feature flexible fiber hollow waveguide delivery technology, ergonomic handpieces designed for precise control, and variable spot-size capability. LightScalpel lasers are used in dental surgery (general dentistry, pediatric, orthodontics, implants, periodontics), oral and maxillofacial surgery, dermatology and plastic surgery, ENT procedures, ophthalmology, gynecology, podiatry, and neurosurgery. The company manufactures all systems domestically in the USA and sells direct to practitioners, eliminating distributor markups. LightScalpel provides product training, continuing education workshops, laser safety certification, and extensive clinical education resources.

NINGBO LINSTANT POLYMER MATERIALS CO., LTD is a specialized manufacturer of high-performance medical-grade polymer tubing and materials for minimally invasive surgical devices. Founded in 2014, the company focuses on extrusion processing, coating technology, and post-processing expertise for catheter and medical device applications. LINSTANT operates approximately 20,000 square meters of GMP-certified cleanroom manufacturing space in Ningbo, equipped with 15 precision extrusion lines, 8 dedicated PEEK extrusion lines, 2 injection molding lines, ~100 braiding/wrapping/coating systems, and 40 welding/forming units. The company specializes in fluoropolymer medical tubing (PTFE, FEP), polyimide (PI), PEEK, and advanced polymers for cardiovascular, neurological, urological, ophthalmological, endoscopic, and orthopedic applications. Core products include micro-catheters, guiding catheters, angiographic catheters, balloon tubing, negative-pressure sheaths, heat-shrink tubing, and customizable multi-layer/multi-lumen structures. The company provides OEM/ODM services including R&D design, rapid prototyping, testing/validation, regulatory assistance (ISO 13485 certified), and full-scale manufacturing for global medical device OEMs.

Omnia Medical is an orthopedic implant and medical device company headquartered in Morgantown, West Virginia, specializing in innovative surgical solutions for spine and interventional pain management. The company develops a comprehensive portfolio of implants and guidance systems designed to reduce operative time and enhance surgical outcomes. Key product lines include sacroiliac joint stabilization and fusion systems (PsiF DNA, PsiF90, PsiFGuard, PsiF), interbody fusion devices for cervical and lumbar applications (TiBrid C, TiBrid SA, Rotary), bone scaffold and matrix products (CeLLogix, DBLogix), and vertebral body replacement systems (Boxcar). Omnia Medical combines advanced engineering with surgeon collaboration to deliver clinically validated solutions that improve patient outcomes and enable surgeons to practice to their full potential.

Quantum Surgical is a French medical robotics and AI company founded in 2017, specializing in robotic-assisted interventional oncology. Headquartered in Montpellier with a Miami office, the company develops and markets the Epione® robotic platform—a CE-marked and FDA 510(k)-cleared system designed for percutaneous tumor ablation in abdominal, chest, and musculoskeletal lesions. Epione integrates planning, navigation, targeting, and ablation confirmation into a single workflow, enabling minimally invasive treatment of early-stage and challenging tumors that are difficult to reach or surgically inaccessible. The platform has treated over 1,500 patients at 20+ cancer centers in Europe and North America. The Epione system standardizes access to ablation therapy, reducing procedural complexity while improving patient safety, reducing recovery time, and enabling outpatient procedures. Quantum Surgical also acquired NeuWave Medical, expanding its portfolio in thermal ablation technologies. With 130+ employees and recognition including the 2022 Prix Galien USA award, the company continues expanding market approvals and clinical installations.

Spinal Simplicity is a medical device manufacturer specializing in minimally invasive spinal and orthopedic fusion implants. Founded in 2008 by Dr. Harold Hess and Todd Moseley, the company develops FDA-cleared surgical solutions for spine conditions, including interspinous fusion, sacroiliac joint fusion, and cervical stabilization devices. The product portfolio includes the Minuteman interspinous fusion device (lateral approach, muscle-sparing), Liberty SI (lateral transfixing sacroiliac fusion implant), Patriot SI (posterior intra-articular titanium SI joint fusion device), Hero SI (hybrid construct combining Liberty and Patriot), Edge Upper Cervical System, and Wolff's Law Anterior Cervical Plate. All devices are engineered according to AO Principles for bone healing and designed to minimize tissue trauma while optimizing joint stability and fusion biology. The company holds over 150 global patents and maintains a clinical focus on reducing patient recovery time and improving long-term outcomes for chronic pain and spinal instability.

Republic Spine is a manufacturer of minimally invasive spinal instrumentation and orthopedic implants. The company specializes in pedicle screw systems and other spine surgical devices designed with direct input from spine surgeons. Republic Spine combines the engineering, quality, and regulatory capabilities of a large medical device manufacturer with responsive customer service and direct surgeon feedback integration. Their product portfolio includes innovative pedicle screw designs such as the DarkStar® system, which features triple-lead thread technology optimized for ease of insertion, reduced surgeon fatigue, and enhanced pullout strength. The company serves both surgeons and medical device distributors, providing spinal instrumentation solutions, surgeon training, and comprehensive customer support focused on improving patient outcomes and surgical efficiency.

ISO13485 certified medical device contract design and manufacturing organization founded in 2002. MediConcepts provides end-to-end expertise spanning consultancy, contract design and development, industrial design, engineering, verification and validation, tooling fabrication, production, clinical evaluation, and distribution services. The company specializes in minimally invasive surgical devices and maintains broad experience across diverse medical device categories. With manufacturing facilities in Shenzhen, China and headquarters in Hong Kong, MediConcepts supports clients from early-stage innovation through regulatory compliance, design review, pre-market notification, and post-market surveillance. The organization emphasizes quality, regulatory compliance (CGMP), and reliable high-volume or low-volume production capabilities.

Miami Fat Supply manufactures and supplies specialized fat harvesting, grafting, and transfer instrumentation for cosmetic and reconstructive surgical procedures. The company's flagship product, the Red Head system, is a large-volume closed-system fat harvesting device designed to protect and preserve adipose tissue for consistent patient outcomes. Miami Fat Supply distributes a comprehensive range of cannulas, handles, adapters, and accessories used by physicians and hospitals nationwide for autologous fat transfer procedures. Product lines include large and small-volume harvesting canisters, injection and infiltration cannulas with multiple port configurations, liposuction instruments, fat transfer adapters, and specialized harvesting accessories. The company emphasizes rapid fulfillment (24/7 ordering, next-business-day shipping) and safe payment processing.

Pleural Dynamics is a Minneapolis-based medical device innovator specializing in minimally invasive solutions for chronic fluid collections within the body. The company's flagship product, ACES (Automatic Continuous Effusion Shunt), is an FDA-cleared implantable device designed to treat chronic recurrent pleural effusions—excess fluid accumulation between the lung and chest wall that causes severe dyspnea, cough, and reduced quality of life. ACES leverages the body's natural breathing motion to automatically and continuously transfer pleural fluid into the abdomen for reabsorption, eliminating the need for repeated drainage procedures, external catheters, or prolonged hospitalization. With a 1-day or less hospital stay, zero 30-day failure rate, and zero pleural infection rate in clinical trials, ACES offers superior clinical outcomes and cost-effectiveness compared to traditional pleurodesis and indwelling pleural catheter approaches. The device targets the approximately 660,000 new patients annually in the US and Europe with recurrent pleural effusions, representing a $1.5B annual market opportunity. Pleural Dynamics addresses a significant clinical unmet need by providing sustained symptom relief while reducing infection risk, caregiver burden, and overall healthcare costs.

Moximed is a medical device company specializing in innovative implants for knee osteoarthritis treatment. The company's core product, the MISHA Knee System, is an implantable shock absorber designed specifically for medial compartment knee OA in patients with mild to moderate disease. The polymer-based device is implanted via minimally invasive outpatient procedure and works by unloading weight from the affected knee compartment, reducing pain and improving function while delaying the need for total knee replacement. Clinical pivotal studies demonstrate 96% of patients reported clinically meaningful pain relief and 92% reported functional improvement. The system enables patients to maintain active lifestyles with quick recovery times, allowing return to normal activities within days. Moximed targets patients who have failed conservative treatments, continue experiencing pain that interferes with daily activities, and are ineligible for or unwilling to undergo knee arthroplasty due to age or disease severity.

Medeologix is a contract development and manufacturing organization (CDMO) specializing in minimally invasive medical devices. The company provides integrated design-for-manufacturing services, rapid prototyping, pilot production, and full-scale mass manufacturing. Core competencies include complex catheter technologies (neuro microcatheters, peripheral vascular catheters, endoscopic catheters, structural heart catheters, ablation catheters, thrombectomy catheters), medical tubing (multi-lumen, multi-layer, thermoplastic elastomeric, braid- and coil-reinforced), and medical balloons (compliant, semi-compliant, non-compliant variants). Secondary capabilities encompass hydrophilic coating services, device assembly, packaging, sterilization management, and supply chain coordination. ISO 13485 certified with ISO Class 7 cleanroom facilities. Medeologix serves global MedTech companies seeking to accelerate product development timelines and optimize manufacturing processes for market launch.

Endovascular Engineering, Inc. (E2) is a clinical-stage medical device company based in Menlo Park, California, specializing in advanced mechanical thrombectomy solutions for venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT). Founded in 2019 by Dr. Luis Savastano and backed by approximately $42 million in venture funding, E2 has developed the Hēlo™ PE Thrombectomy System—a minimally invasive catheter-based device designed to safely and effectively remove blood clots from the lungs. The Hēlo system features a unique self-expanding funnel design that delivers large-bore clot engagement through a small-profile catheter, reducing vascular trauma and hemodynamic compromise. Its dual-action technology combines high-speed mechanical agitation with simultaneous physician-controlled aspiration for single-pass clot disruption and removal. The system received FDA Investigational Device Exemption approval in January 2024 and is currently in pivotal clinical trials. E2 targets underserved peripheral VTE indications and aims to redefine the standard of care in endovascular thrombectomy.

JENOPTIK is a global photonics technology group headquartered in Jena, Germany, with approximately 4,500 employees and €1.12 billion in annual revenue (FY 2024). The company specializes in optics, lasers, sensors, and integrated photonic systems serving medical technology, semiconductor manufacturing, metrology, and smart mobility sectors. JENOPTIK operates a high-tech manufacturing facility in Dresden producing micro-optics for semiconductor equipment. Key subsidiaries Aesculap-Meditec and TRIOPTICS expand its specialized medical and precision optics offerings. The company provides comprehensive photonic solutions including micro-optical components, laser systems for industrial applications, vision and imaging technologies for life sciences and diagnostics, and automated manufacturing systems. JENOPTIK is listed on the SDAX and TecDAX exchanges.

Paramount Surgicals, Inc. is an innovative spinal implant manufacturer specializing in FDA-approved devices for the treatment of spinal disorders across the lumbar, thoracic, and cervical regions. Founded by spine surgeons and mechanical engineers, the company designs implants that adhere to biomechanical principles of normal spine anatomy, offering versatility, stability, reliability, and surgical maneuverability. The product portfolio includes fixation systems, interbody fusion devices, pedicle screw systems, and dynamic plating solutions. The company is actively developing next-generation technologies including artificial disc replacement systems and expanding international market presence beyond established U.S. distribution channels.

Palette Life Sciences is a medical device company specializing in Non-Animal Stabilized Hyaluronic Acid (NASHA) technologies for interventional urology, urogynecology, colorectal conditions, radiotherapy, and interventional oncology. The company develops innovative tissue bulking and spacer agents designed to address specialized clinical needs often underserved by larger medical device manufacturers. Acquired by Teleflex Incorporated in October 2023, Palette Life Sciences' product portfolio includes spacers for prostate cancer radiotherapy, tissue bulking agents for vesicoureteral reflux management, and solutions for fecal incontinence. The company's NASHA-based technology platform enables minimally invasive interventions across urology, gynecology, and colorectal specialties.

Wenzel Spine, Inc. is a medical technology company founded in 2008 and headquartered in Austin, Texas, specializing in minimally invasive surgical solutions and diagnostic platforms for spinal disorders. The company is a recognized leader in stand-alone spine fusion technologies with over 17 years of expertise in expandable implant design and manufacturing. Wenzel Spine develops a comprehensive portfolio of devices designed to simplify spine surgery, reduce recovery time, and improve patient outcomes while preserving spinal anatomy and minimizing hardware burden. The company's mission emphasizes a "less is more" approach, often eliminating the need for supplemental fixation. With 21,000+ devices implanted, 11,000+ patients treated, and 300+ surgeon partners across North America and the European Union, Wenzel Spine maintains a strong commitment to ethical practices and regulatory compliance. The company serves orthopedic surgeons and spine specialists treating sacroiliac, lumbar, and cervical fusion patients through both innovative surgical systems and diagnostic software.

RenovoRx is a clinical-stage life sciences and biopharmaceutical company developing targeted oncology therapies and commercializing RenovoCath, an FDA-cleared drug-delivery device for solid tumor cancer treatment. The company's proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform enables direct, targeted delivery of therapeutic agents to tumors via the peripheral vascular system, particularly for pancreatic cancer applications. RenovoCath is indicated for temporary vessel occlusion, arteriography, preoperative occlusion, and chemotherapeutic drug infusion in arteries 3–11 mm in diameter. The company is actively advancing a Phase III clinical trial (TIGeR-PaC) evaluating intra-arterial gemcitabine (IAG) versus systemic intravenous chemotherapy for locally advanced pancreatic cancer, with FDA Orphan Drug Designation. RenovoCath has secured initial purchase orders from National Cancer Institute-designated medical centers and has obtained international patent protections, including Japanese patent allowances for targeted local drug delivery via the vasa vasorum pathway.

Virtual Incision Corporation develops miniaturized robotic-assisted surgery (miniRAS) systems designed to democratize access to robotic-assisted surgery across healthcare facilities. The company's flagship product, the MIRA Surgical System, is the first FDA-cleared miniaturized robotic platform weighing approximately two pounds and deployable through a single abdominal incision. Unlike traditional mainframe robotic surgery systems, MIRA enables hospitals to perform robotic-assisted procedures in outpatient and ambulatory surgery centers, reducing capital barriers and expanding surgical capacity. The system is designed for general surgery abdominal procedures including colon resection and hysterectomy, with demonstrated remote surgical capabilities. Founded in 2006 by Dr. Dmitry Oleynikov and Dr. Shane Farritor, Virtual Incision holds over 200 patents and has raised more than $100 million in funding. The company's mission centers on making minimally invasive robotic surgery accessible to more patients, surgeons, and healthcare facilities by providing cost-effective alternatives to large-footprint robotic systems.

OsteoRemedies, LLC is an FDA-cleared orthopedic medical device manufacturer specializing in complex joint infection management and revision arthroplasty solutions. Founded in 2013 and headquartered in Memphis, Tennessee, the company designs and produces innovative devices for two-stage infection revisions of hip, knee, and shoulder joints. The product portfolio includes the proprietary REMEDY® Spacer System, antibiotic-loaded bone cements, debridement instruments, irrigation solutions, and antimicrobial wound management systems. OsteoRemedies addresses the critical clinical need for effective biofilm management and infection control in orthopedic surgery, offering surgeons comprehensive toolsets to optimize patient outcomes in complex revision procedures. The company maintains AdvaMed Code of Ethics compliance and emphasizes quality assurance and continuous product improvement.

Francis Medical develops the Vanquish® Water Vapor Ablation System, an FDA-cleared, minimally invasive medical device designed for targeted thermal ablation of prostate tissue via transurethral approach. The system uses sterile water vapor energy to treat localized prostate cancer and benign prostatic conditions. Founded in 2018 and based in Maple Grove, Minnesota, Francis Medical specializes in urological oncology solutions that minimize long-term side effects associated with traditional prostate treatments. The Vanquish System is designed for outpatient use with transurethral delivery incorporating standard cystoscopy and transrectal ultrasound. Clinical data from the VAPOR 2 multi-center pivotal study (n=235) demonstrates 91% clearance of targeted MRI-visible disease, low rates of urinary incontinence (2.7% Grade 2 or higher), low rates of erectile dysfunction, and high patient satisfaction (93% extremely satisfied/satisfied at 12 months). The system treats prostate lesions in any anatomical location including apex, anterior, and transition zone. Commercial adoption is expanding across U.S. surgery centers.

CardioVia is an Israeli medical device manufacturer specializing in minimally invasive cardiac access technologies. The company's flagship product, ViaOne™, is an FDA-cleared epicardial access system that enables safe, precise entry into the heart's pericardial space using a proprietary blunt-tip concealed needle design, eliminating the risk of cardiac perforation associated with traditional sharp-needle approaches. ViaOne™ incorporates a bio-impedance pressure sensor for real-time placement confirmation and a tissue-gripping mechanism that separates tissue without cutting. The platform supports multiple cardiac interventions including arrhythmia ablation, epicardial lead implantation, left atrial appendage closure (LAAC), and emerging regenerative therapies (stem cell, gene therapy, targeted drug delivery). The device has achieved FDA Breakthrough Device Designation, 510(k) clearance, and publication of feasibility and preclinical validation studies in peer-reviewed journals (JACC: Clinical Electrophysiology, Journal of Interventional Cardiac Electrophysiology). CardioVia is backed by Terumo Corporation and is launching commercialization across U.S. cardiac centers.

Joline Medical Inc. is the North American distribution subsidiary of Joline GmbH & Co. KG (Germany), specializing in minimally invasive kyphoplasty solutions for vertebral compression fractures. Founded in 1999, Joline designs and manufactures high-precision kyphoplasty systems, including the Stop'n GO Double Balloon system, for treatment of osteoporotic and traumatic vertebral fractures. All products are developed and hand-assembled in Germany under strict quality controls and meet FDA and European regulatory standards. Joline serves hospitals, outpatient surgery centers, and specialty spine clinics, offering clinical education, anatomical training workshops, and dedicated U.S. support. The company emphasizes precision engineering, reliable performance, and patient outcome focus in restoring vertebral height and reducing pain.

TrackX Technology is a medical device manufacturer specializing in universal instrument tracking technology for surgical applications, particularly orthopedic and trauma procedures. The company's core product, TrackX, provides real-time virtual live fluoroscopy during surgery using disposable tracking components (TrackX Snap) that attach to surgical instruments and implants. The system recalibrates with each new x-ray, eliminating the need for bulky equipment or capital purchases. Key clinical benefits include significant radiation dose reduction (91.8% reduction in radiation exposure), substantial reduction in x-ray frequency (74.8% fewer x-rays required), and meaningful OR time savings (average 56-minute reduction per procedure). The three-step setup process—apply Snap, take x-ray, track in real-time—simplifies adoption and reduces sterilization burdens. Designed for surgeons, hospital executives, and surgical teams seeking efficiency and safety improvements in minimally invasive and open surgical procedures.

New Wave Endo develops innovative surgical technologies designed to improve surgical outcomes, reduce complications, and decrease postoperative pain while reducing opioid dependence. The company's core team previously developed the D-HELP laparoscopic defogging device (now Clearify™ by Medtronic), which has been used in millions of procedures. Their flagship product, the M-Close Kit, addresses port site closure and hernia prevention in minimally invasive surgery, with particular focus on challenging anatomies such as obese patients. The solution provides targeted fascial plane closure technology and fascial plane targeting capabilities. New Wave Endo's technologies support opioid-free recovery protocols and enhance safety in laparoscopic and minimally invasive surgical procedures across major healthcare systems.

Erbe USA Incorporated is the U.S. subsidiary of Erbe Elektromedizin GmbH, a German medical technology manufacturer with over 170 years of heritage in surgical instruments and advanced electrosurgical systems. The company specializes in electrosurgery, plasmasurgery, cryosurgery, hydrosurgery, and irrigation/insufflation technologies designed for precise tissue cutting, coagulation, ablation, and minimally invasive surgical procedures. Erbe's product portfolio supports diverse surgical specialties including general surgery, orthopedics, gynecology, pulmonology, and ENT applications. The company emphasizes clinical quality, reproducibility, and regulatory compliance, supported by comprehensive technical service centers, maintenance programs, and continuing education initiatives for healthcare professionals.

SolcoAmerica, a Dallas-based subsidiary of Solco Biomedical (founded 1974 in Korea), specializes in the design and manufacture of orthopedic spinal implants and minimally invasive surgical instrumentation systems. Established in the US in 2013, the company focuses on developing progressive spinal care solutions for spine surgeons treating patients with spinal pathologies. Their product portfolio encompasses anterior cervical plate systems, minimally invasive screw fixation sets, interbody cages, and kyphoplasty systems across cervical, thorocolumbar, and biologics segments. The company maintains a global distribution network and serves over 200 physicians with a commitment to advancing spinal care through continuous R&D and innovation in both open and minimally invasive surgical approaches.

NeoChord, Inc. is a privately held medical technology company specializing in beating heart mitral valve repair. The company manufactures the NeoChord Artificial Chordae Delivery System (Model DS1000), an echo-guided, minimally invasive treatment for patients with mitral valve regurgitation. The device enables direct repair of the mitral valve on a beating heart without requiring cardiopulmonary bypass, preserving the valve structure and future treatment options. The system uses artificial chords deployed via transapical access under echocardiographic guidance. NeoChord's technology improves procedural control, restores mitral valve function, and has been evaluated in multiple clinical studies across numerous countries. The company holds CE marking conformity under European Medical Device Regulation (MDR) 2017/745. In the United States, the device is investigational and limited to investigational use by federal law. NeoChord serves cardiac surgeons, interventional cardiologists, and cardiac care centers treating mitral valve disease. The company maintains a focus on clinical evidence generation, with multiple peer-reviewed publications documenting feasibility, safety, and efficacy of the procedure, including novel applications such as re-repair and use in complex anatomies.

Nextern Innovation is a vertically integrated medical device contract design, development, and manufacturing organization (CDMO). The company collaborates with innovators and clinicians to design, develop, optimize, and manufacture medical devices across multiple therapeutic areas. Nextern operates four global manufacturing facilities totaling 250,000 square feet, including 20,000 square feet of cleanroom space, with a team of 600+ members worldwide. The company specializes in minimally invasive devices, single-use catheter and metal assemblies, Class III active implantable leads and delivery systems, power systems (catheter and generator development), bioelectronics, and connected care solutions. Nextern Liink, a subsidiary, develops custom, secure, and scalable software solutions for medical device connectivity. Core capabilities include device design and development (bio-simulation, pre-clinical testing, IP support), full-spectrum manufacturing with phased transition from development to commercialization, supply chain management, and life-cycle services including warranty and continuous improvement. The company operates virtual quality management systems and maintains presence in strategically located global manufacturing locations with localized supply chains. Nextern serves cardiology, neuromodulation, and other specialty device markets, with demonstrated expertise in brain-computer interfaces and platforms for labeling and graphical user interfaces.

Bentley InnoMed GmbH is an international medical technology company headquartered in Hechingen, southern Germany, specializing in endovascular solutions for peripheral and aortic vascular diseases. The company develops, manufactures, and markets implants and catheters for minimally invasive treatment of vascular pathologies including aneurysms, stenosis, and coarctation. Since 2012, Bentley has established itself as a market leader in Europe, with flagship products including the BeGraft covered stent line, BeFlared FEVAR systems, and BeFlow iliac stents. These devices are recognized as gold standards in endovascular interventions and are supported by a global distribution network spanning over 80 countries. Bentley serves interventional radiologists, cardiologists, and vascular surgeons in hospitals and specialized intervention centers, emphasizing precision engineering, clinical efficacy, and improved patient outcomes in vascular care.

Trimedyne, Inc. is a premier manufacturer of Holmium:YAG surgical laser systems and proprietary fiber optic delivery devices. Founded in 1980 and ISO 13485:2016 certified, Trimedyne specializes in minimally invasive surgical applications across urology, orthopedics, spine surgery, gynecology, gastroenterology, ENT, and general surgery. The company's flagship OmniPulse MAX laser features proprietary DoublePulse technology that effectively doubles tissue ablation effect while reducing bleeding and trauma to surrounding tissue. Trimedyne offers integrated fiber power output verification, advanced cooling systems for sustained full-power delivery, and a comprehensive range of surgical handpieces, laser fibers, and surgical needles with both standard SMA 905 and proprietary connectors. Products are designed to reduce hospital stays and accelerate patient recovery through precision tissue ablation in lithotripsy, spinal disc procedures, joint arthroscopy, and soft tissue applications.

Theator is a SaaS-based surgical intelligence platform that converts intraoperative video from laparoscopic and robotic procedures into structured clinical and billing data. The company's flagship product, Surgery-to-Text®, uses proprietary AI trained on hundreds of thousands of real procedures to generate billing-ready operative reports with >95% accuracy directly from surgical video—significantly exceeding the ~73% accuracy of manually written reports. The platform integrates seamlessly with existing OR camera infrastructure (laparoscopic and robotic systems) regardless of manufacturer and embeds directly into Epic and Oracle Health EHRs. Theator addresses multiple enterprise pain points: surgeon documentation burden (reducing operative note finalization time by ~70%), coding and billing accuracy (reducing claim denials and rework), quality and safety monitoring, and surgeon burnout. The company is trusted by leading health systems performing 100,000+ procedures annually. Theator meets enterprise security and compliance standards including HIPAA, HITRUST R2, SOC 2 Type II, ISO 27001, and ISO 27799. The platform is software-centric and agnostic to OR equipment, deploying in weeks without workflow disruption. Marketed to hospital systems and surgical centers seeking to extract actionable intelligence from the 60% of hospital revenue driven by surgery while reducing manual documentation overhead and improving operative report accuracy for clinical, billing, and research applications.

Osseus Fusion Systems is a Dallas-based medical device manufacturer specializing in minimally invasive spinal fusion and fixation solutions. Founded by industry veterans with over 35 years of combined experience, the company develops innovative pedicle screw systems, interbody fusion devices, and anterior cervical plates utilizing advanced materials, 3D printing, and additive manufacturing technologies. The product portfolio includes the Black Diamond Pedicle Screw System (open and minimally invasive variants), White Pearl Anterior Cervical Plate, Gemini-C Cervical Interbody system, Aries interbody family (TS, TC, L variants for lumbar applications), Blue Topaz Sacroiliac Screw System, and Black Diamond POCT. Osseus emphasizes biocompatible, radiolucent materials with osseoconductive properties and close surgeon collaboration to optimize biomechanical performance and patient outcomes. The company operates with 11-50 employees and approximately $5.5 million in revenue.

HMDmd develops wearable surgical display technology designed to enhance visualization and ergonomics in minimally invasive surgery. The company's CR3 Wearable Surgical Monitor provides surgeons with high-fidelity color imaging and natural 3D visualization without polarizer distortion, improving depth perception in both 2D and 3D surgical environments. The device connects to standard imaging platforms and is engineered to reduce surgeon fatigue while maintaining situational awareness during complex procedures. HMDmd serves surgical teams seeking advanced visualization tools for challenging intraoperative scenarios, positioning itself as a purpose-built solution for enhanced surgical vision and ergonomic positioning.

Nutek Orthopaedics manufactures advanced minimally-invasive external fixation systems for orthopedic surgery, leveraging over 50 years of surgeon-informed design experience. Their proprietary technology features axial freedom for precision K-wire placement, spherical pin-locking mechanisms, and radiolucent Ultem® plates enabling real-time fluoroscopic visualization. Products address shoulder, wrist, hand, and general orthopedic trauma applications. The systems prioritize reduced operative time, low infection rates, preserved vascularity, minimal soft-tissue damage, and early patient mobility without permanent implants—enabling rapid return to normal function.

MicroAire Surgical Instruments is a manufacturer of powered surgical instruments and minimally invasive surgical devices, specializing in orthopedic and plastic surgery applications. Founded in 1977 and headquartered in Charlottesville, Virginia, the company designs, manufactures, and distributes innovative surgical solutions globally. MicroAire's core product portfolio includes the PAL (Power-Assisted Liposuction) system, which delivers 35% reduction in surgical time and 49% reduction in surgeon fatigue compared to traditional liposuction; the SmartRelease endoscopic carpal tunnel release system, employed in over 2 million procedures worldwide; and the Endotine multipoint fixation system for tissue suspension and facial lifting procedures. The company also distributes complementary surgical technologies including hapo exoskeletons for plastic surgeons and ADIMATE/ADIPURE automated lipofilling systems. MicroAire emphasizes clinical reliability, surgeon ergonomics, and patient outcomes through advanced powered instrumentation and minimally invasive surgical techniques.

Biorep Technologies is an ISO 13485-certified, FDA-registered medical device contract design and manufacturing organization (CDMO) based in Miami Lakes, Florida. Founded in 1994, the company specializes in end-to-end medical device development and manufacturing services, including rapid prototyping, design verification, process development and validation, contract manufacturing, and assembly services. With over 30 years of experience, Biorep serves medical device companies across cardiovascular, minimally invasive surgical instruments, ENT devices, and diabetes research equipment sectors. The company maintains a vertically integrated structure with capabilities spanning concept through scale-up, production launch, and lifecycle support. Biorep partners with global med-tech innovators and maintains a strategic partnership with the Diabetes Research Institute, providing essential research equipment for type I diabetes initiatives. The company operates with documented design controls, traceability systems, supply chain management, and regulatory compliance infrastructure compatible with US, EU, and Asian markets.

Expanding Innovations, Inc. (EI) designs and manufactures next-generation expandable interbody fusion cage systems for spinal surgery. The company specializes in non-screw-based expandable cage technology designed to address post-operative vertebral body subsidence and cage collapse—critical complications in minimally invasive lumbar fusion procedures. EI's X-PAC® product line comprises the X-PAC TLIF (transforaminal lumbar interbody fusion), X-PAC LLIF (lateral lumbar interbody fusion), and X-PAC N-GAGE lumbar plate system with modular coupling. The X-PAC technology relocates the lifting mechanism from within the cage to the inserter instrument, enhancing expansion control, tactile feedback, and adaptability to individual patient bone quality. All systems feature unidirectional locking teeth for controlled expansion and open architecture supporting post-operative bone packing. EI's devices are indicated for addressing degenerative spine conditions, particularly in aging populations where bone quality is compromised. The company markets to spine surgeons and surgical centers performing minimally invasive and open spinal fusion procedures. Regulatory status and specific certifications (FDA 510(k), ISO 13485) are not detailed on the fetched content.

Deep Blue Medical Advances develops next-generation surgical devices focused on soft tissue surgery and hernia repair. The company's core portfolio includes the T-Line® Hernia Mesh, a novel mesh system designed to address common failure modes in hernia repair, particularly suture pull-through and tissue dehiscence. The T-Line® Hernia Mesh is currently in use in surgical suites across the United States and targets the $1.1 billion global hernia device market. The company is also developing the T-Line® TCS (Tissue Control Suture) for general soft tissue procedures, intended to improve procedure speed, safety, and durability while reducing patient pain from tissue trauma. Additional products under development include the T-Line® Scaffold for breast surgery applications and an Anchor Clip for simplified mesh implantation. The company offers both investigational and commercial-stage devices and is pursuing variants including biosynthetic and coated composite versions of their hernia mesh platform. Deep Blue has been recognized with the 2024 Luis Villalobos Award for Innovative Company of the Year in Life Sciences, indicating clinical and market validation of their surgical technology approach.

NovApproach Spine develops innovative solutions for anterior lumbar interbody fusion (ALIF) surgery, specifically designed to simplify surgical approaches and improve patient outcomes. The company's flagship product is the OneLIF™ cage system, a patented interbody implant engineered for single-position anterior lumbar spine surgery. The OneLIF device features a unique design allowing trials and implants to be inserted in both straight and oblique directions with lateral screw fixation from the left side, minimizing soft tissue retraction and vascular exposure compared to traditional ALIF approaches. The system is designed to accommodate a wide range of anatomies while reducing the need for extensive surgical exposure. NovApproach Spine collaborates with leading academic spine surgeons and spinal access surgeons to develop both surgical approaches and corresponding implants that represent advances in lumbar implant versatility. The company emphasizes efficiency, versatility, and surgeon collaboration as core differentiators. Products are marketed toward spine specialists, neurosurgeons, and orthopedic surgeons performing anterior lumbar reconstruction procedures. The technology is positioned as addressing key limitations of traditional ALIF techniques, particularly for cases with limited exposure or complex vascular/neural anatomy. While specific FDA clearance or regulatory credentials are not detailed on the fetched site, the company's focus on surgical innovation and implant design suggests compliance with orthopedic device regulations.

BoneBac manufactures minimally invasive surgical devices for bone graft collection and processing during orthopedic procedures. The company's primary product, the BoneBac Press, is a single-use, pre-sterilized device that enables surgeons to harvest, collect, and process autologous bone from the surgical site during fusion procedures. This technology reduces reliance on allograft bone substitutes and synthetic bone alternatives, potentially lowering per-surgery costs by over 80% while increasing the volume of available bone for fusion applications. The device is designed to streamline intraoperative bone collection and processing, minimizing operative time and eliminating the need for secondary donor site harvesting. BoneBac has been manufacturing medical devices in the United States since 2011 and is based in Sandown, New Hampshire. The company holds FDA registration and ISO 13485:2016 certification, indicating compliance with medical device manufacturing and quality management standards. Products are currently marketed and sold within the United States only.

CORONEO Inc. is a Canadian medical device manufacturer specializing in innovative cardiac surgery solutions since 1997. The company designs and manufactures high-precision surgical instruments and implants for minimally invasive aortic valve repair and coronary artery stabilization. CORONEO's flagship product, the EXTRA-AORTIC Ring, is the market-leading external annuloplasty device for aortic valve repair, with over 2,500 successful implants globally. The company also produces the COR-VALV System (adjustable tissue retractors), COR-VASC System (reusable stabilization platform for beating heart bypass), PEDIATRIC Retractors (titanium retractors for pediatric cardiac surgery), and SWIFT-LOOP Vessel Loops (atraumatic vessel occlusion devices). All products are fabricated from premium titanium alloys and certified ISO 13485:2016, with regulatory approvals including CE Mark, FDA, and Health Canada. CORONEO maintains in-house prototype facilities, plastic injection molding, and clean room capabilities, enabling rapid design iteration and medium-volume production. The company serves hospitals and surgical centers across North America, Europe, and Asia through a dedicated distributor network.

Rex Medical LP is a medical device manufacturer specializing in minimally invasive solutions for cardiovascular, venous access, endosurgery, and oncology applications. The company develops and markets innovative devices designed to address unmet clinical needs in these therapeutic areas. Their primary product offering includes the REVOLUTION™ Peripheral Atherectomy System, a device used for peripheral vascular intervention. Rex Medical is ISO 13485 certified, indicating compliance with medical device quality management system standards. The company focuses on delivering high-quality patient care through technology-driven innovation in the minimally invasive medical device sector.